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Abstract: Previous studies have demonstrated that ayurvedic ingredients exhibit ergogenic
(performance enhancing) properties, however, no previous studies have examined the ergogenic
potential of Asparagus racemosus. The purpose of the present study was to examine the ergogenic
efficacy of supplementation with 500 mg·d−1 of A. racemosus during bench press training. Eighteen
recreationally trained men (mean ± SD; age = 20.4 ± 0.5 yrs; height = 179.7 ± 1.5 cm; weight = 84.7
± 5.7 kg) were randomly assigned either 500 mg·d−1 of A. racemosus (n = 10) or placebo (n = 8).
An overlapping sample of 10 participants were used to determine test-retest reliability. Pre- and
post-training testing included bench press with one repetition maximum (1RM) and repetitions to
failure at 70% of pre-training 1RM. The participants performed two sets of bench press to failure
three times a week for eight weeks. Independent t-tests, Analyses of covariance (ANCOVA), and
regression analyses were used to analyze the dependent variables. The results demonstrated greater
mean percentage (14.3 ± 7.7% vs. 7.8 ± 4.5%; p = 0.048) and individual (80% vs. 50%) increases in
1RM, mean (17.5 ± 2.2 repetitions vs. 15.2 ± 2.2 repetitions; p = 0.044) and individual (80% vs. 38%)
increases in repetitions to failure, and a greater rate of increase in training loads for the Asparagus
racemosus group than the placebo group. In conjunction with bench press training, supplementation
with A. racemosus provided ergogenic benefits compared to placebo.
Keywords: Asparagus racemosus; resistance training; bench press; supplement; Ayurveda

1. Introduction
Ayurveda is an ancient medical tradition originating in India that has grown in popularity
as an alternative medicine [1]. Ayurveda consists of eight divisions of healing and approximately
1250 plants that have been used for Ayurvedic formulations to treat a wide range of ailments [2].
In Ayurveda, Asparagus racemosus is one of the most popular adaptogens that is classified as a
rasayana, a plant that improves vitality, immunity, and vigor [1,3]. A member of the Asparagaceae
family, A. racemosus is characterized as a tuberous, climbing plant found throughout Asia, Australia,
and Africa [4]. A. racemosus has previously been demonstrated to elicit antitussive, antibacterial,
antihepatotoxic, immunomodulatory, and antioxidant effects in both rat and human models [4].
The primary phytochemicals found in A. racemosus include saponins, such as shatavarin VI and
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shatavarin VII [5], as well as antioxidants such as asparagamine A, racemosol, and racemofuran [2].
Steroidal saponins are a diverse group of glycosides whose structural complexity results in a wide
range of biological and chemical properties [6] that may be a source of health benefits associated with
herbal medicines [7,8]. Antioxidants are enzymatic and nonenzymatic agents that neutralize and
reduce the damage elicited by reactive oxygen species which are overproduced during strenuous bouts
of aerobic and anaerobic exercise [9]. Under some conditions, antioxidant supplementation has been
shown to positively affect exercise performance [10,11]. No studies, however, have investigated the
ergogenic (performance enhancing) potential of supplementation with A. racemosus.
Previous studies have suggested that Ayurvedic ingredients may also function as an ergogenic
aid [12–15]. Specifically, Wankhede et al. [12] demonstrated that eight weeks of resistance training and
supplementation with 600 mg·d−1 of ashwagandha root extract resulted in greater improvements in
upper and lower body strength, muscle size, body composition, serum testosterone, and markers of
muscle recovery compared to placebo in untrained men. Das et al. [13] demonstrated that 12 weeks
of 250 mg·d−1 of shilajit supplementation with a four week aerobic training program promoted
collagen and extracellular matrix-associated gene transcription in overweight/obese men and
women. Furthermore, Keller et al. [14] demonstrated that following eight weeks of 500 mg·d−1
of shilajit supplementation attenuated fatigue and reduced baseline levels of serum hydroxyproline in
recreationally trained men. Tanabe et al. [15] reported attenuated declines in force production and
serum creatine kinase activity compared to placebo following 150 mg of curcumin before and 150 mg
of curcumin after eccentric muscle actions of the forearm flexors. Thus, previous studies [12–15] have
shown that Ayurvedic ingredients may have ergogenic properties that enhance the adaptations to
exercise training.
Previous research has demonstrated improved physical performance following supplementation
with ayurvedic extracts, supplements, and ingredients [12–15]. Furthermore, A. racemosus has potential
properties [4,5] that may lead to similar improvements in exercise performance [12–15]. Therefore,
the purpose of the present study was to examine the ergogenic efficacy of supplementation with
500 mg·d−1 of A. racemosus during bench press training. Based on the result of previous studies [12–15],
it was hypothesized that daily supplementation with A. racemosus would improve measures of muscular
strength and endurance compared to placebo.
2. Materials and Methods
2.1. Participants
Twenty-six men volunteered to participate in this study (Table 1). Ten of the participants were
randomly assigned to the A. racemosus group and eight to the placebo group. An overlapping sample
of 10 men (age = 22.0 ± 2.3 years; height = 177.8 ± 6.9 cm; body mass = 76.3 ± 24.2 kg) were used to
determine the test-retest reliability for the dependent variables and calculate the minimal difference (MD)
statistic [16]. Two of the 10 participants used for the test-retest reliability analyses were also participants
in the A. racemosus group (n = 1) or the placebo group (n = 1). All participants were recreationally trained
and had previously participated in resistance training exercises [17]. The participants had no known
prior cardiovascular, metabolic, pulmonary, or musculoskeletal diseases. In addition, the participants
reported no use of any medication, nutritional product, dietary supplement, or dietary program within
the last month which would have interfered with the conduct of the study. The study was approved
by the Institutional Review Board for Human Subjects at The University of Nebraska-Lincoln (IRB #
20190219049FB, date: 19 month 2019). The participants signed a written informed consent and health
history questionnaire prior to participation.
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2.2. Familiarization Visit
The first laboratory visit consisted of an orientation session to familiarize the participants with the
testing and training protocols. During the orientation, the participants performed submaximal bench
press repetitions. The participants then scheduled their pre-training test visit.
Table 1. Participant Characteristics.

Age (years)
Height (cm)
Body Mass (kg)
Pre-Training
Post-Training

Asparagus Racemosus

Placebo

20.1 ± 1.2
180.7 ± 6.3

20.7 ± 1.1
178.6 ± 5.5

88.2 ± 12.8
88.6 ± 13.0

81.4 ± 11.0
80.5 ± 11.6

Note: There were no significant (p > 0.05) pre-training differences between the A. racemosus and placebo groups for
age, height, or body mass. Furthermore, there were no pre-training versus post-training changes in body mass for
the A. racemosus or placebo groups.

2.3. Pre-Training Test Visit
During the pre-training test visit, the participants performed a one-repetition maximum strength
test (1RM) and a bench press repetitions-to-failure test. The bench press was performed on a standard
free-weight bench (Body Power, Williamsburg, VA, USA) with a traditional Olympic barbell. After an
initial lift off from a spotter, the participants were instructed to control the barbell down until it made
contact with their chest, then lift the barbell back to a locked-out position in a controlled movement.
During all bench press repetitions, a spotter was standing in position behind the bench to prepare to
lift the barbell in the event the participant was unable to successfully complete a repetition. The 1RM
was performed according to the guidelines established by the National Strength and Conditioning
Association [18]. Specifically, a light warm-up set was performed for 5–10 repetitions at 50% of their
estimated 1RM, followed by 2–3 heavier warm up sets of 2–5 repetitions with loads increasing by
10–20% each set. The participants then began completing sets of 1 repetition with increasing loads
(5–10%) until they were no longer able to complete a single repetition. Verbal encouragement was
provided, and two minutes of rest were allotted between sets. The highest load (kg) successfully
lifted through the entire range of motion with proper technique was considered a 1RM. The 1RM was
determined within 3 to 5 sets. After 10 min of rest, bench press repetitions to failure was assessed by
participants performing one set of as many repetitions to failure with a load corresponding to 70% of
the 1RM established during the pre-training test visit. Failure was defined as the inability to complete
a proper repetition [18]. The participants were then randomized in either 500 mg d−1 of A. racemosus
(Natreon Inc., New Brunswick, NJ, USA; n = 10) or 500 mg·d−1 of placebo (n = 8; microcrystalline
cellulose) and instructed to consumed 2 capsules (250 mg each) of their assigned supplement once a day
for 8 weeks. All capsules were identical in size, appearance, and taste. At the end of the pre-training
test visit, participants were instructed to complete and return a 3-day dietary recall form.
2.4. Training Visits
The training visits were supervised and performed 3 days a week for 8 weeks. Prior to the start of
each training session, an investigator confirmed that the participants were consuming their assigned
supplement and asked whether they had experienced any adverse events. During each training visit,
the participants warmed up with 2 to 3 sets of low load resistance, then completed 2 sets of bench
press to failure with loads initially corresponding to 80% of their 1RM. Verbal encouragement was
provided during each set and two minutes of rest was allotted between sets. If a participant was able
to perform more than 8 repetitions on the second set, 2.3 kg was added to the start of the next training
session. In the last week of the of the study, the participants were instructed to complete and return a
second 3-day dietary recall form.

J. Funct. Morphol. Kinesiol. 2020, 5, 4

4 of 11

2.5. Post-Training Test Visit
Following 8 weeks of training and supplementation, the participants underwent a post-training
test visit using the same testing protocol as the pre-training test visit. The post-training test visit
included a 1RM bench press and bench press repetitions to failure at 70% of the pre-training 1RM.
2.6. Reliability of Bench Press 1RM and Endurance
Repeated measures of bench press 1RM and bench press repetitions-to-failure tests were assessed
2–7 days apart to determine test-retest reliability. The participants (n = 10) performed a 1RM, followed
by bench press repetitions to failure and the protocols used were identical to those used during the
pre-training and post-training test visits.
2.7. Statistical Analyses
Analyses of covariance (ANCOVA) were used to determine differences between the A. racemosus
and placebo groups for post-training bench press 1RM and repetitions to failure, covaried for pre-training
values. Independent samples t-tests were used to compare the percent change in bench press 1RM
and bench press repetitions to failure between the A. racemosus and placebo groups. The training
loads for each visit across the eight weeks were log transformed and linear regression analyses were
performed to compare the slope coefficients for the training load versus training visit relationship
between the A. racemosus and placebo groups. Separate 2 (Group [A. racemosus and Placebo]) × 2 (Time
[Pre-training and Post-training]) mixed factorial ANOVAs were used to compare total caloric and
macronutrient intakes across the training period. Test-retest reliability for bench press 1RM and bench
press repetitions to failure were assessed with a repeated measures ANOVA to identify systematic
error and a 2,k model was used to determine the intraclass correlation coefficient (ICC) and minimal
difference (MD) [16]. Specifically, the formula used to calculate the MD was [16]:
MD = SEM × 1.96 ×

√
2

where the SEM is the standard error of the measurement that was estimated from the square root
of the mean square error from the ANOVA analyses [16]. While various methods are available to
estimate the SEM, using the mean square error as opposed to methods utilizing the ICC allows for
more consistency in interpreting the SEM across different studies [16]. Effect sizes (η2 p and Cohen’s d)
were calculated for each comparison and an alpha of p < 0.05 was considered statistically significant
for all tests. The statistical analyses were performed using IBM SPSS v 25 (Armonk, NY, USA).
3. Results
3.1. Reliability
The test-retest reliability for mean differences (systematic error), ICCs, and MD for bench press
1RM and repetitions to failure were calculated using the 2,k model described by Weir [16]. There were
no mean differences between test versus retest of the bench press 1RM (104.8 ± 22.7 vs. 105.7 ± 22.6;
p = 0.440, η2 p = 0.067) and bench press repetitions to failure (13.4 ± 1.4 vs. 14.4 ± 1.3; p = 0.051, η2 p =
0.360) (Table 2).
3.2. Adverse Events, Adherence, Compliance, and Dietary Recall
The participants reported no adverse or serious adverse events during the study and all of the
participants completed 24 bench press training sessions. The participants reported consuming all
daily doses of their assigned supplement throughout the eight week training period. There were no
significant interactions (p = 0.149–0.812; η2 p = 0.004–0.126) or main effects for Group (p = 0.149–0.812;
η2 p = 0.004–0.126) or Time (p = 0.225–0.970; η2 p = 0.000–0.091) for total calories, carbohydrate, fat, and
protein intake from their three day dietary recalls (Table 3).
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Table 2. Test-retest reliability for bench press one repetition maximum (1RM) and bench press repetitions
to failure.

1RM (kg)
Repetitions to
Failure

Visit 1
(Mean ± SD)

Visit 2
(Mean ± SD)

104.8 ± 22.7

105.6 ± 22.6

0.440

13.8 ± 1.5

14.4 ± 1.3

0.051

p-Value ICC

ICC 95% CI

SEM

CV (%)

MD

0.994

0.98–0.99

2.53

2.4

7.01

0.90

0.58–0.97

0.68

4.8

1.90

CV (%) = coefficient of variation; ICC = interclass correlation coefficient; ICC 95%; CI = interclass correlation
coefficient 95% confidence interval; MD = minimal difference needed to be considered real; p-value = type I error
rate for the one-way repeated measures analyses used to assess systematic variability; SEM = standard error of
the measurement.

Table 3. Mean ± SD of total calories, carbohydrate, fat, and protein consumption across 3 days before
and after training.
Pre-Training

Total Calories (kcal)
Carbohydrate (g)
Fat (g)
Protein (g)

Post-Training

Asparagus Racemosus

Placebo

Asparagus Racemosus

Placebo

1623.1 ± 524.2
154.1 ± 45.1
61.0 ± 23.5
112.8 ± 83.3

1639.0 ± 505.1
170.5 ± 55.5
54.4 ± 19.1
102.3 ± 35.0

1544.1 ± 432.15
138.6 ± 50.5
73.9 ± 45.4
97.8 ± 53.5

1953.2 ± 946.6
218.7 ± 151.2
65.5 ± 27.2
118.6 ± 45.6

3.3. Bench Press 1RM and Bench Press Repetitions to Failure
There was no significant (p = 0.196, η2 p = 0.109) difference for the adjusted mean bench press
1RM between the A. racemosus (106.1 ± 5.1 kg) and placebo (102.7 ± 5.1 kg) groups when covaried
for pre-training values (Table 4). The results of the independent samples t-test demonstrated that the
A. racemosus group had a significantly (p = 0.048) greater percent change in bench press 1RM (14.3 ±
7.7%) compared to the placebo group (7.8 ± 4.5 %; d = 1.06) (Table 4). The MD for a change to be real for
bench press 1RM of an individual participant was 7.01 kg, based on the reliability data (Table 2). In the
A. racemosus group, eight of the 10 participants exceeded the MD while four of the eight participants in
the placebo group exceeded the MD.
Table 4. Individual values as well as absolute and adjusted mean ± SD values for pre-training and
post-training bench press 1RM.
Participant

Pre-Training
1RM (kg)

1
2
3
4
5
6
7
8
9
10

70.3
79.4
124.7
83.9
115.7
102.1
52.2
90.7
102.1
79.4

Mean
Adjusted Mean

90.0 ± 21.7

Post-Training
1RM (kg)

Absolute
Change (kg)

Asparagus Racemosus Group
83.9
93.0
124.7
102.1
124.7
115.7
65.8
97.5
115.7
93.0
101.6 ± 18.9
106.1 ± 5.1

Percent
Change (%)

13.6 *
13.6 *
0.0
18.2 *
9.1 *
13.6 *
13.6 *
6.8
13.6 *
13.6 *

19.3
17.1
0.0
21.6
7.8
13.3
26.1
7.5
13.3
17.1

11.6 ± 5.1

14.3 ± 7.7 **
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Table 4. Cont.
Participant

Pre-Training
1RM (kg)

Post-Training
1RM (kg)

Absolute
Change (kg)

Percent
Change (%)

1
2
3
4
5
6
7
8

83.9
79.4
65.8
142.9
102.1
111.1
97.5
120.2

Placebo Group
93.0
81.7
68.0
154.2
115.7
117.9
111.1
124.7

9.1 *
2.3
2.3
11.3 *
13.6 *
6.8
13.6 *
4.5

10.8
2.9
3.5
7.9
13.3
6.1
14.0
3.8

Mean
Adjusted Mean

100.4 ± 24.6

7.9 ± 4.7

7.8 ± 4.5

108.3 ± 26.9
102.7 ± 5.1

* Minimal
difference
for a PEER
change
to be “real” for an individual participant in bench press 1RM was 7.01 7 of 11
J. Funct.
Morphol.
Kinesiol.(MD)
2020,value
5, x FOR
REVIEW
kg, based on reliability data in Table 2. ** Percent change (%) in 1M bench press for the A. racemosus group was
greater than the placebo group at p = 0.048. Adjusted mean ± SD post-test values were covaried for pre-training
7 A. racemosus group and
15 the placebo group.19
4*
26.7
values for the

8
15
18
3*
20.0
Mean
13.5
±
1.6
15.1
±
2.3
1.6
±
1.5
12.2
± 11.1
The A. racemosus group demonstrated significantly (p = 0.044) greater adjusted mean bench
press
2
Adjusted
Mean(17.5 ± 2.2 repetitions) than
15.2 ±the
2.2placebo group (15.2 ± 2.2; η p = 0.243) when
repetitions
to failure
covaried
for pre-training
(Table
There was
significant
difference
(p = 0.058)
in thepress
percent
* Minimal
differencevalues
(MD) value
for5).
a change
to beno
“real”
for an individual
participant
in bench
changerepetitions
for benchtopress
repetitions
to
failure
between
the
A.
racemosus
(33.2
±
27.8
%)
and
placebo
failure was 1.90 repetitions, based on reliability data in Table 2. ** Adjusted post-training
groupsrepetitions
(12.2 ± 11.1
d = 1.00)
(Table
5). The MD
forwas
thegreater
changethan
to bethe
real
for bench
press
to %;
failure
for the
A. racemosus
group
placebo
group
at p repetitions
= 0.044.
to failure
was 1.9
repetitions,
based
on the
reliability
(Table 2). In
the A.
group,group
eight of
Adjusted
mean
± SD post-test
values
were
covarieddata
for pre-training
values
forracemosus
the A. racemosus
the 10 and
participants
exceeded
the
MD,
while
three
of
the
8
participants
in
the
placebo
group
exceeded
the placebo group.
the MD.
3.4. Training Load
3.4. Training Load
Over eight weeks of training, the rate of change in the bench press training loads was
Over eight(pweeks
of training,
the the
rateA.
of racemosus
change in the
bench
press
training
loads was
significantly
significantly
< 0.001)
greater for
group
(slope
= 0.004
± 0.0005)
than
the placebo
(pgroup
< 0.001)
greater
for
the
A.
racemosus
group
(slope
=
0.004
±
0.0005)
than
the
placebo
group
(slope =
(slope = 0.002 ± 0.0002) (Figure 1).
0.002 ± 0.0002) (Figure 1).

Figure 1. Regression analyses of the log-transformed training loads for the A. racemosus (AR) group (–)
and the placebo group (—). * Indicates the slope coefficient for the A. racemosus group was significantly
Figure 1. Regression analyses of the log-transformed training loads for the A. racemosus (AR) group
(p < 0.001) greater than the placebo group.
(─) and the placebo group (---). * Indicates the slope coefficient for the A. racemosus group was
significantly (p < 0.001) greater than the placebo group.

4. Discussion
The purpose of the present study was to examine the ergogenic efficacy of A. racemosus during
eight weeks of bench press training. The results of the study demonstrated that supplementing with
500 mg·d−1 of A. racemosus, in conjunction with bench press training three days per week, resulted in

J. Funct. Morphol. Kinesiol. 2020, 5, 4

7 of 11

Table 5. Individual values as well as absolute and adjusted mean ± SD values for pre-training and
post-training bench press repetitions to failure.
Participant

Pre-Training
Repetitions

1
2
3
4
5
6
7
8
9
10

12
14
14
13
15
15
10
15
11
17

Mean
Adjusted Mean

13.6 ± 2.1

1
2
3
4
5
6
7
8

14
14
11
11
14
14
15
15

Mean
Adjusted Mean

13.5 ± 1.6

Post-Training
Repetitions

Absolute Change
(Repetitions)

Asparagus Racemosus Group
20
15
13
18
18
17
19
19
16
20
17.5 ± 2.3
17.5 ± 2.2 **
Placebo Group
14
14
12
14
15
15
19
18
15.1 ± 2.3
15.2 ± 2.2

Percent
Change (%)

8*
1
1
5*
3*
2*
9*
4*
5*
3*

66.7
7.1
7.0
38.5
20.0
13.3
90.0
26.7
45.5
17.6

4.1 ± 2.7

33.2 ± 27.4

0
0
1
3*
1
1
4*
3*

0.0
0.0
9.1
27.3
7.1
7.1
26.7
20.0

1.6 ± 1.5

12.2 ± 11.1

* Minimal difference (MD) value for a change to be “real” for an individual participant in bench press repetitions to
failure was 1.90 repetitions, based on reliability data in Table 2. ** Adjusted post-training repetitions to failure for
the A. racemosus group was greater than the placebo group at p = 0.044. Adjusted mean ± SD post-test values were
covaried for pre-training values for the A. racemosus group and the placebo group.

4. Discussion
The purpose of the present study was to examine the ergogenic efficacy of A. racemosus during
eight weeks of bench press training. The results of the study demonstrated that supplementing with
500 mg·d−1 of A. racemosus, in conjunction with bench press training three days per week, resulted
in a 6.5% greater increase in bench press 1RM (14.3 ± 7.7% vs. 7.8 ± 4.5%) and a greater increase
in bench press repetitions to failure (17.5 ± 2.2 repetitions vs. 15.2 ± 2.2 repetitions) compared to
placebo. Furthermore, daily supplementation with A. racemosus allowed for a greater rate of increase
in training load throughout the eight weeks compared to the placebo group. Thus, the results of the
present study suggested that supplementation with A. racemosus facilitated greater increases in training
loads throughout the eight weeks of resistance training that likely contributed to the improvements in
muscular strength and endurance.
The results of the test-retest reliability data demonstrated that the bench press 1RM and bench
press repetitions to failure were highly reliable measures of muscular strength and endurance (Table 2).
Calculation of the MD values from the reliability analyses in the present study indicated that for
individual participants, training-induced changes in bench press 1RM and bench press repetitions to
failure of 7.0 kg and 1.9 repetitions, respectively, were required to be considered “real” [16]. A recent
review [19] has characterized individuals as high or low responders to training-induced adaptations
to resistance training. Thus, it is important to examine the training-induced responses of individual
participants, as well as group mean responses. The findings of the present study demonstrated no
mean difference between groups for improvements in absolute bench press 1RM (Table 4), but a greater
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mean improvement in absolute bench press repetitions to failure (Table 5) for the A. racemosus group
than the placebo group. On an individual basis, however, 80% of the participants in the A. racemosus
group exceeded the MD of 7.01 kg needed to be considered a real change for the bench press 1RM, while
only 50% of participants exceeded the MD for the placebo group. For bench press repetitions to failure,
80% of the participants in the A. racemosus group exceeded the MD of 1.9 repetitions to failure needed
to be considered a real change, compared to 38% of the participants in the placebo group. Calculation
of the MD in the present study allowed for a practical interpretation of the training-induced changes in
muscular strength and endurance on a participant by participant basis [16]. Thus, the results of the
present study demonstrated that supplementation with A. racemosus elicited greater improvements
for bench press 1RM and bench press repetitions to failure compared to placebo on an individual
participant basis that were only partially reflected in the group mean analyses (Tables 4 and 5).
In the present study, supplementation with A. racemosus over eight weeks elicited a greater rate of
increase in the training loads compared to the placebo group (Figure 1). The greater rate of increase in
the training load for the A. racemosus group likely contributed the greater mean increase in bench press
repetitions to failure, as well as the greater percentage of “real” individual increases in both bench press
1RM and bench press repetitions to failure compared to the placebo group. It is possible that the greater
rate of increase in training loads over a longer period of resistance training plus supplementation with
A. racemosus would lead to greater mean and individual increases in muscular strength and endurance.
No previous studies have examined the influence of supplementation with A. racemosus on exercise
performance. In the Ayurvedic tradition, A. racemosus has been utilized as an adaptogen [2–4] in
part due to its antioxidant [4,20] properties. Reactive oxygen species, such as those produced during
exercise [21], undergo oxidative reactions with cellular mechanisms that can impair muscle function
and growth through the disruption of cellular functions such as myofibrillar calcium dynamics and
gene transcription [22,23]. Enzymatic and nonenzymatic antioxidants function to buffer, scavenge,
and minimize the deleterious effects of reactive oxygen species [24,25]. Wiboonpun et al. [26]
reported the presence of antioxidants in A. racemosus including asparagamine A, racemosol, and
racemofuran. Furthermore, Kamat et al. [20] demonstrated that supplementation with A. racemosus
attenuated mitochondrial oxidative stress elicited by radiation-induced reactive oxygen species in
the rat model. Although there is conflicting evidence [27,28], the use of antioxidants as an ergogenic
aid has demonstrated improvements in exercise performance [10,11,29,30]. For example, Aguilo et
al. [29] reported that the antioxidant effects of 90 days of vitamin E and ß-carotene supplementation
during duathlon training resulted in improved lactate buffering and utilization. Bowtell et al. [30]
found that the antioxidant effects associated with seven days of Montmorency cherry juice concentrate
supplementation led to improved force recovery and lower creatine kinase activity 24 and 48 h
following a muscle-damaging protocol that included 10 sets of 10 repetitions of leg extensions at
80% of 1RM. Levers et al. [11] showed that the antioxidant effects of 10 days of powdered tart cherry
supplementation reduced the perception of muscle soreness and serum creatinine concentrations
following 10 sets of 10 repetitions of back squat at 70% of 1RM. During submaximal cycle ergometry,
McKenna et al. [10] reported a greater time to exhaustion and improved plasma potassium regulation
with continuous infusion of the antioxidant N-acetylcysteine. In the present study, exercise-induced
oxidative stress [23] may have been mitigated by the antioxidant properties of A. racemosus, which
enhanced muscle recovery and reduced muscle soreness on a day-to-day basis that contributed to
the greater rate of increase in training load throughout the eight weeks of training. The antioxidant
effects of A. racemosus may have also contributed to the mean improvements in muscular endurance
and the higher percentage of individual participants who exhibited real training-induced increases
in bench press 1RM and bench press repetitions to failure. Further research is needed to determine
if there are mechanisms, in addition to antioxidant properties, that underly the ergogenic efficacy of
supplementation with A. racemosus.
Limitations of the present study include the low mean total caloric and macronutrient consumption
values from the 3-day dietary recall when compared to the dietary recommendations for the participants’
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age demographic [31]. Previous studies, however, have demonstrated that dietary recalls are subject
to systematic underreporting of nutritional intake [32]. The present study utilized only the bench
press to assess muscular strength and endurance. It remains unclear whether the ergogenic efficacy of
A. racemosus supplementation is limited to resistance training modalities and when supplemented by
men. In addition, the participants self-reported their adherence to daily supplementation but were not
supervised in the taking of their assigned supplement.
5. Conclusions
This is the first study that has examined the effects of supplementation with A. racemosus on
exercise performance. The results demonstrated that during the eight weeks of resistance training,
supplementation with 500 mg·d−1 of A. racemosus elicited greater mean percentage and individual
increases in bench press 1RM, mean and individual increases in bench press repetitions to failure, and
a greater rate of increase in bench press training loads compared to placebo. It was hypothesized
that the ergogenic effects of A. racemosus were due to its antioxidant properties. Future studies are
warranted to examine the ergogenic efficacy of A. racemosus with exercise modalities other than upper
body resistance training.
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